Related Experiment Video
Updated: Jul 12, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Enhanced Production of Sisomicin in Micromonospora inyoensis by Protoplast Mutagenesis and Fermentation Optimization
Jianguo Xu1,2, Shulin Shen3,4, Zhehua Hu1
1Laboratory of Pharmaceutical Engineering, School of Life Science and Health Engineering, Jiangnan University, Wuxi, 214122, China.
Abstract:
Sisomicin is a broad-spectrum aminoglycoside antibiotic and is the precursor of netilmicin and plazomicin. However, the fermentation level of sisomicin is still low compared with other antibiotics, which restricts the application of sisomicin and its derivatives. In this study, to improve sisomicin production, breeding of high-yielding sisomicin strains was conducted with chemical mutagenesis using Micromonospora inyoensis OG-1 (titer, 1042 U·mL-1) as the starting strain. Protoplast preparation was conducted under optimal conditions, and protoplast mutagenesis was performed with a suitable concentration of diethyl sulfate. Subsequently, a high-yielding and genetically stable strain (H6-32) was obtained by screening, with a sisomicin titer of 1486 U·mL-1 (an increase of 42.6%). Finally, carbon and nitrogen sources were optimized to further improve sisomicin production, and a sisomicin titer of 1780 U·mL-1 was ultimately obtained by controlling the dissolved oxygen level at 30% in a 5-L fermenter, which to the best of our knowledge is the highest reported titer ever achieved by fermentation. Comparative genome analysis showed that a total of 13 genes in the genome of the mutant strain H6-32 were mutated compared to the original strain. This study not only provides a reference for further breeding of high-yielding strains and fermentation optimization, but also enhances our understanding of sisomicin production.
Insights
This study enhanced sisomicin (a broad-spectrum aminoglycoside antibiotic) production by developing a high-yielding strain through chemical mutagenesis and optimizing fermentation conditions. The resulting strain achieved a record fermentation titer of 1780 U·mL-1.
Area of Science:
- Microbiology
- Biotechnology
- Fermentation Science
Background:
- Sisomicin, a key aminoglycoside antibiotic and precursor to netilmicin and plazomicin, suffers from low fermentation yields.
- Limited production restricts the broader application of sisomicin and its clinically significant derivatives.
Purpose of the Study:
- To significantly improve sisomicin production through strain breeding and fermentation optimization.
- To achieve the highest possible fermentation titer for sisomicin.
Main Methods:
- Chemical mutagenesis of Micromonospora inyoensis OG-1 using diethyl sulfate on protoplasts.
- Screening for high-yielding, genetically stable mutant strains.
- Optimization of carbon and nitrogen sources and dissolved oxygen levels in fermentation.
Main Results:
- A high-yielding mutant strain (H6-32) was developed, increasing sisomicin titer by 42.6% to 1486 U·mL-1.
- Optimized fermentation conditions, including dissolved oxygen control, yielded a final sisomicin titer of 1780 U·mL-1.
- Comparative genome analysis identified 13 gene mutations in the high-yielding strain H6-32.
Conclusions:
- The study successfully developed a high-yielding sisomicin strain and optimized fermentation, achieving a record titer.
- This work provides a valuable reference for future strain development and fermentation process optimization in antibiotic production.
- The findings contribute to a deeper understanding of the genetic basis of sisomicin overproduction.
Related Concept Videos
Bioreactor Controls-III
Upstream Processing
Production of Alcohol
Production of Antibiotics
Production of Pharmaceuticals
iChip

